Related Experiment Video
Updated: Dec 19, 2025
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.2K
Molecular characterization of diffuse malignant peritoneal mesothelioma
Yin P Hung1,2, Fei Dong3, Matthew Torre3
1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. yphung@mgh.harvard.edu.
Summary
This study categorizes malignant peritoneal mesothelioma into BAP1-mutant and BAP1-wild-type groups. Findings reveal key genetic alterations, implicating DNA repair and epigenetics in mesothelioma development and suggesting therapeutic targets.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Malignant peritoneal mesothelioma is a rare, aggressive cancer.
- Molecular drivers, especially in BAP1-wild-type cases, are poorly understood.
Purpose of the Study:
- To molecularly characterize diffuse malignant peritoneal mesotheliomas.
- To identify distinct genetic subtypes and potential therapeutic targets.
Main Methods:
- Targeted next-generation sequencing of 26 diffuse malignant peritoneal mesotheliomas.
- Exploratory analysis of additional peritoneal mesothelioma subtypes.
- Immunohistochemistry for BAP1 expression.
Main Results:
- Two main groups identified: BAP1-altered (69%) and BAP1-wild-type (31%).
- BAP1-altered tumors frequently had PBRM1 and SETD2 alterations; BAP1 loss correlated with expression loss.
- BAP1-wild-type tumors showed diverse mutations including TP53, TRAF7, SUZ12, and ALK rearrangements.
Conclusions:
- Diffuse malignant peritoneal mesothelioma can be genetically classified into BAP1-mutant and BAP1-wild-type categories.
- Pathogenesis involves DNA repair, epigenetics, and cell cycle regulation.
- Identified genetic alterations may serve as therapeutic targets.
